For the quarter ending 2025-09-27, CPSH had $860,105 increase in cash & cash equivalents over the period. $876,808 in free cash flow.
| Cash Flow | 2025-09-27 | 2025-06-28 |
|---|---|---|
| Product sales | 8,803,694 | - |
| Cost of product sales | 7,301,129 | - |
| Gross profit | 1,502,565 | - |
| Selling, general, and administrative expenses | 1,226,484 | - |
| Income (loss) from operations | 276,081 | - |
| Other income, net | 45,484 | - |
| Net income (loss) before income taxes | 321,565 | - |
| Income tax provision (benefit) | 113,601 | - |
| Net income (loss) | 207,964 | 199,795 |
| Depreciation and amortization | 137,289 | 321,189 |
| Share-based compensation | 49,354 | 171,540 |
| Realized gain on sale of marketable securities | -713 | 12,183 |
| Deferred taxes | -113,601 | -135,828 |
| Accounts receivables-Trade Accounts Receivable | -202,623 | 744,495 |
| Accounts receivables-Other Receivables | -39,377 | 238,961 |
| Inventories | 185,435 | 867,180 |
| Prepaid expenses and other current assets | 64,614 | -217,350 |
| Accounts payable | 243,829 | 232,511 |
| Accrued expenses | 261,807 | 123,184 |
| Deferred revenue | 43,874 | -142,045 |
| Net cash provided by (used in) operating activities | 1,050,382 | -603,467 |
| Purchases of property and equipment | 173,574 | 265,918 |
| Acquisition cost of patents and trademarks | 4,542 | 21,363 |
| Proceeds from sale of marketable securities | 509,000 | 518,000 |
| Purchase of marketable securities | 521,161 | 525,772 |
| Net cash used in investing activities | -190,277 | -295,053 |
| Payments on note payable | 0 | 8,130 |
| Net cash used in financing activities | 0 | -8,130 |
| Net decrease in cash and cash equivalents | 860,105 | -906,650 |
| Cash and cash equivalents at beginning of period | 3,280,687 | - |
| Cash and cash equivalents at end of period | 3,234,142 | - |
CPS TECHNOLOGIES CORP DE (CPSH)
CPS TECHNOLOGIES CORP DE (CPSH)